$25.00
In chiusura: Sep 11 EDT
$25.01
0.010.04%
Pre-mercato: 7:55 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Travere Therapeutics Inc (NASDAQ:TVTX) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 12.11M a 12.08M. Questo rappresenta il 13.65% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Travere Therapeutics Corp (XNAS:TVTX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 1.65M azioni scambiate al giorno, ci vorrebbero 7.32 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
12.08M
Vendite allo scoperto %
13.7%
Giorni di copertura
7.32
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
TVTX | Travere Therapeutics, Inc. Com | 08/29/2025 | 09/10/2025 | 13.65% | 88,517,698 | 12,081,747 | 1,650,536 | 7.32 | |
TVTX | Travere Therapeutics, Inc. Com | 08/15/2025 | 08/26/2025 | 13.68% | 88,517,698 | 12,107,746 | 1,713,433 | 7.07 | |
TVTX | Travere Therapeutics, Inc. Com | 07/31/2025 | 08/11/2025 | 12.00% | 88,517,698 | 10,624,378 | 1,168,621 | 9.09 | |
TVTX | Travere Therapeutics, Inc. Com | 07/15/2025 | 07/24/2025 | 16.02% | 80,268,582 | 12,859,589 | 1,297,625 | 9.91 | |
TVTX | Travere Therapeutics, Inc. Com | 06/30/2025 | 07/10/2025 | 15.57% | 80,268,582 | 12,499,883 | 1,530,659 | 8.17 | |
TVTX | Travere Therapeutics, Inc. Com | 06/13/2025 | 06/25/2025 | 12.87% | 80,268,582 | 10,329,311 | 1,586,851 | 6.51 | |
TVTX | Travere Therapeutics, Inc. Com | 05/30/2025 | 06/10/2025 | 15.58% | 80,268,582 | 12,502,367 | 2,149,464 | 5.82 | |
TVTX | Travere Therapeutics, Inc. Com | 05/15/2025 | 05/27/2025 | 13.00% | 80,268,582 | 10,434,682 | 1,704,041 | 6.12 | |
TVTX | Travere Therapeutics, Inc. Com | 04/30/2025 | 05/09/2025 | 13.25% | 80,268,582 | 10,637,755 | 1,401,750 | 7.59 | |
TVTX | Travere Therapeutics, Inc. Com | 04/15/2025 | 04/25/2025 | 13.76% | 80,268,582 | 11,046,107 | 2,146,190 | 5.15 | |
TVTX | Travere Therapeutics, Inc. Com | 03/31/2025 | 04/09/2025 | 14.40% | 80,268,582 | 11,556,812 | 1,632,731 | 7.08 | |
TVTX | Travere Therapeutics, Inc. Com | 03/14/2025 | 03/25/2025 | 13.95% | 80,268,582 | 11,194,840 | 1,567,861 | 7.14 | |
TVTX | Travere Therapeutics, Inc. Com | 02/28/2025 | 03/11/2025 | 13.64% | 80,268,582 | 10,948,550 | 1,782,562 | 6.14 | |
TVTX | Travere Therapeutics, Inc. Com | 02/14/2025 | 02/26/2025 | 14.08% | 80,268,582 | 11,301,636 | 2,269,818 | 4.98 | |
TVTX | Travere Therapeutics, Inc. Com | 01/31/2025 | 02/11/2025 | 12.16% | 78,563,059 | 9,555,755 | 1,277,344 | 7.48 | |
TVTX | Travere Therapeutics, Inc. Com | 01/15/2025 | 01/27/2025 | 12.19% | 78,563,059 | 9,577,154 | 1,215,520 | 7.88 | |
TVTX | Travere Therapeutics, Inc. Com | 12/31/2024 | 01/10/2025 | 11.10% | 78,563,059 | 8,719,387 | 1,356,793 | 6.43 | |
TVTX | Travere Therapeutics, Inc. Com | 12/13/2024 | 12/24/2024 | 9.43% | 78,563,059 | 7,405,769 | 1,061,515 | 6.98 | |
TVTX | Travere Therapeutics, Inc. Com | 11/29/2024 | 12/10/2024 | 9.64% | 78,563,059 | 7,574,947 | 1,178,702 | 6.43 | |
TVTX | Travere Therapeutics, Inc. Com | 11/15/2024 | 11/26/2024 | 8.87% | 78,563,059 | 6,971,485 | 1,545,857 | 4.51 | |
TVTX | Travere Therapeutics, Inc. Com | 10/31/2024 | 11/11/2024 | 11.75% | 68,020,241 | 7,991,229 | 1,148,956 | 6.96 | |
TVTX | Travere Therapeutics, Inc. Com | 10/15/2024 | 10/24/2024 | 11.92% | 68,020,241 | 8,107,720 | 2,956,643 | 2.74 | |
TVTX | Travere Therapeutics, Inc. Com | 09/30/2024 | 10/09/2024 | 10.24% | 68,020,241 | 6,962,090 | 2,344,321 | 2.97 | |
TVTX | Travere Therapeutics, Inc. Com | 09/13/2024 | 09/24/2024 | 12.73% | 68,020,241 | 8,657,111 | 2,582,902 | 3.35 | |
TVTX | Travere Therapeutics, Inc. Com | 08/30/2024 | 09/11/2024 | 13.60% | 68,020,241 | 9,253,644 | 693,685 | 13.34 | |
TVTX | Travere Therapeutics, Inc. Com | 07/31/2024 | 08/09/2024 | 14.83% | 68,020,241 | 10,085,762 | 969,300 | 10.41 | |
TVTX | Travere Therapeutics, Inc. Com | 07/15/2024 | 07/24/2024 | 14.93% | 67,657,774 | 10,099,233 | 1,182,373 | 8.54 | |
TVTX | Travere Therapeutics, Inc. Com | 06/28/2024 | 07/10/2024 | 15.25% | 67,657,774 | 10,320,666 | 1,761,121 | 5.86 | |
TVTX | Travere Therapeutics, Inc. Com | 06/14/2024 | 06/26/2024 | 19.83% | 67,657,774 | 13,414,704 | 837,545 | 16.02 | |
TVTX | Travere Therapeutics, Inc. Com | 05/31/2024 | 06/11/2024 | 19.90% | 67,657,774 | 13,466,678 | 1,040,843 | 12.94 | |
TVTX | Travere Therapeutics, Inc. Com | 05/15/2024 | 05/24/2024 | 19.87% | 67,657,774 | 13,441,029 | 1,209,992 | 11.11 | |
TVTX | Travere Therapeutics, Inc. Com | 04/30/2024 | 05/09/2024 | 18.94% | 67,657,774 | 12,811,095 | 1,373,404 | 9.33 | |
TVTX | Travere Therapeutics, Inc. Com | 04/15/2024 | 04/24/2024 | 17.45% | 67,637,585 | 11,802,198 | 1,352,724 | 8.72 | |
TVTX | Travere Therapeutics, Inc. Com | 03/28/2024 | 04/09/2024 | 15.67% | 67,637,585 | 10,601,943 | 988,081 | 10.73 | |
TVTX | Travere Therapeutics, Inc. Com | 03/15/2024 | 03/26/2024 | 13.30% | 75,730,599 | 10,071,652 | 1,191,648 | 8.45 | |
TVTX | Travere Therapeutics, Inc. Com | 02/29/2024 | 03/11/2024 | 13.55% | 75,730,599 | 10,260,892 | 1,290,410 | 7.95 | |
TVTX | Travere Therapeutics, Inc. Com | 01/31/2024 | 02/09/2024 | 13.28% | 74,777,945 | 9,930,252 | 1,313,136 | 7.56 | |
TVTX | Travere Therapeutics, Inc. Com | 01/12/2024 | 01/24/2024 | 12.98% | 74,777,945 | 9,706,853 | 1,596,172 | 6.08 | |
TVTX | Travere Therapeutics, Inc. Com | 12/29/2023 | 01/10/2024 | 13.27% | 74,777,945 | 9,919,315 | 1,209,394 | 8.2 | |
TVTX | Travere Therapeutics, Inc. Com | 12/15/2023 | 12/27/2023 | 12.90% | 74,777,945 | 9,644,767 | 2,292,358 | 4.21 | |
TVTX | Travere Therapeutics, Inc. Com | 11/30/2023 | 12/11/2023 | 13.31% | 74,777,945 | 9,953,359 | 1,311,154 | 7.59 | |
TVTX | Travere Therapeutics, Inc. Com | 11/15/2023 | 11/27/2023 | 14.25% | 74,777,945 | 10,656,025 | 2,183,179 | 4.88 | |
TVTX | Travere Therapeutics, Inc. Com | 10/31/2023 | 11/09/2023 | 11.78% | 74,777,945 | 8,805,307 | 1,520,475 | 5.79 | |
TVTX | Travere Therapeutics, Inc. Com | 10/13/2023 | 10/24/2023 | 11.75% | 74,642,979 | 8,773,932 | 1,266,825 | 6.93 | |
TVTX | Travere Therapeutics, Inc. Com | 09/29/2023 | 10/10/2023 | 11.28% | 74,642,979 | 8,418,473 | 3,804,764 | 2.21 | |
TVTX | Travere Therapeutics, Inc. Com | 09/15/2023 | 09/26/2023 | 12.11% | 74,642,979 | 9,039,530 | 1,139,751 | 7.93 | |
TVTX | Travere Therapeutics, Inc. Com | 08/31/2023 | 09/12/2023 | 11.46% | 74,642,979 | 8,552,883 | 1,024,836 | 8.35 |
In cerca di azioni più vendute allo scoperto?